Deng Y - Search Results

1

Dual-target inhibitors based on PARP1: new trend in the development of anticancer research.

Ge J, Yin Y, Li Y, Deng Y, Fu H. Ge J, et al. Among authors: deng y. Future Med Chem. 2022 Apr;14(7):511-525. doi: 10.4155/fmc-2021-0292. Epub 2022 Mar 8. Future Med Chem. 2022. PMID: 35257598 Review.

2

Inhibitors of Cyclin-Dependent Kinase 1/2 for Anticancer Treatment.

Mou J, Chen D, Deng Y. Mou J, et al. Among authors: deng y. Med Chem. 2020;16(3):307-325. doi: 10.2174/1573406415666190626113900. Med Chem. 2020. PMID: 31241436 Review.

3

Design, synthesis, and primary activity assays of baicalein derivatives as cyclin-dependent kinase 1 inhibitors.

Mou J, Qiu S, Chen D, Deng Y, Tekleab T. Mou J, et al. Among authors: deng y. Chem Biol Drug Des. 2021 Oct;98(4):639-654. doi: 10.1111/cbdd.13917. Epub 2021 Jul 19. Chem Biol Drug Des. 2021. PMID: 34233076

4

Design, synthesis, and evaluation of 4-(3-(3,5-dimethylisoxazol-4-yl)benzyl)phthalazin-1(2H)-one derivatives: potent BRD4 inhibitors with anti-breast cancer activity.

Li Y, Chu X, Yin Y, Li H, Fu H, Feng X, Deng Y, Ge J. Li Y, et al. Among authors: deng y. Front Pharmacol. 2023 Nov 30;14:1289003. doi: 10.3389/fphar.2023.1289003. eCollection 2023. Front Pharmacol. 2023. PMID: 38099141 Free PMC article.

5

Targeting NAD Metabolism: Rational Design, Synthesis and In Vitro Evaluation of NAMPT/PARP1 Dual-Target Inhibitors as Anti-Breast Cancer Agents.

Li Y, Kong X, Chu X, Fu H, Feng X, Zhao C, Deng Y, Ge J. Li Y, et al. Among authors: deng y. Molecules. 2024 Jun 14;29(12):2836. doi: 10.3390/molecules29122836. Molecules. 2024. PMID: 38930900 Free PMC article.

6

Design, Synthesis, and Activity Assays of Cyclin-Dependent Kinase 1 Inhibitors With Flavone Scaffolds.

Fu L, Mou J, Deng Y, Ren X, Qiu S. Fu L, et al. Among authors: deng y. Front Chem. 2022 Aug 8;10:940427. doi: 10.3389/fchem.2022.940427. eCollection 2022. Front Chem. 2022. PMID: 36003621 Free PMC article.

7

Insight on Structural Modification, Cytotoxic or Anti-Proliferative Activity, Structure-Activity Relationship of Berberine Derivatives.

Yin M, Mou J, Sun L, Deng Y, Ren X. Yin M, et al. Among authors: deng y. Med Chem. 2023;19(9):823-837. doi: 10.2174/1573406419666230403120956. Med Chem. 2023. PMID: 37016520

8

Butenolide derivatives from Aspergillus terreus selectively inhibit butyrylcholinesterase.

Cui X, Deng S, Li G, Zhang Y, Wang L, Wu C, Deng Y. Cui X, et al. Among authors: deng y, deng s. Front Chem. 2022 Dec 21;10:1063284. doi: 10.3389/fchem.2022.1063284. eCollection 2022. Front Chem. 2022. PMID: 36618870 Free PMC article.

9

Comprehensive analysis of Polygoni Multiflori Radix of different geographical origins using ultra-high-performance liquid chromatography fingerprints and multivariate chemometric methods.

Sun LL, Wang M, Zhang HJ, Liu YN, Ren XL, Deng YR, Qi AD. Sun LL, et al. J Food Drug Anal. 2018 Jan;26(1):90-99. doi: 10.1016/j.jfda.2016.11.009. Epub 2016 Dec 22. J Food Drug Anal. 2018. PMID: 29389593 Free PMC article.

10

In vitro and in vivo evaluation of the influences of polysaccharides derived from Glycyrrhiza uralensis on three alkaloids and potential interaction mechanisms.

Sun L, You G, Zheng F, Wang M, Ren X, Deng Y. Sun L, et al. Among authors: deng y. Int J Biol Macromol. 2020 Aug 15;157:452-460. doi: 10.1016/j.ijbiomac.2020.04.140. Epub 2020 Apr 24. Int J Biol Macromol. 2020. PMID: 32339577

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,327 results

Search Page

Filters